BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 37659030)

  • 1. Incidence of Inflammatory Bowel Disease in New Zealand Remains High, Findings in the Manawatū Region.
    Morton H; Coad J; Pedley KC; Irwin JR
    Dig Dis Sci; 2023 Nov; 68(11):4230-4242. PubMed ID: 37659030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammatory bowel disease in Waikato, New Zealand: incidence and prevalence.
    Seleq S; Weilert F; Fulforth J
    Intern Med J; 2023 Dec; 53(12):2307-2312. PubMed ID: 36916153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High incidence of inflammatory bowel disease in Northern Australia: a prospective community population-based Australian incidence study in the Mackay-Isaac-Whitsunday region.
    Flanagan A; Allsopp SM; O'Connor SA; Tobin J; Pretorius C; Brown IS; Bell S; Daveson AJM
    Intern Med J; 2023 Sep; 53(9):1602-1609. PubMed ID: 36579712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in the epidemiology of inflammatory bowel disease in Colombia by demographics and region using a nationally representative claims database and characterization of inflammatory bowel disease phenotype in a case series of Colombian patients.
    Juliao-Baños F; Kock J; Arrubla M; Calixto O; Camargo J; Cruz L; Hurtado J; Clavijo A; Donado J; Schwartz S; Abreu MT; Damas OM
    Medicine (Baltimore); 2021 Feb; 100(7):e24729. PubMed ID: 33607817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in incidence and clinical features of inflammatory bowel disease in Cardiff, UK over 50 years: an update for 2005-2016.
    Arms-Williams B; Hawthorne AB; Cannings-John R; Berry A; Harborne P; Trivedi A
    Scand J Gastroenterol; 2023 Jun; 58(6):619-626. PubMed ID: 36562277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rising Incidence of Inflammatory Bowel Disease in Canterbury, New Zealand.
    Su HY; Gupta V; Day AS; Gearry RB
    Inflamm Bowel Dis; 2016 Sep; 22(9):2238-44. PubMed ID: 27482976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spatial cluster mapping and environmental modeling in pediatric inflammatory bowel disease.
    Michaux M; Chan JM; Bergmann L; Chaves LF; Klinkenberg B; Jacobson K
    World J Gastroenterol; 2023 Jun; 29(23):3688-3702. PubMed ID: 37398882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crohn's disease and ulcerative colitis. Occurrence, course and prognosis during the first year of disease in a European population-based inception cohort.
    Burisch J
    Dan Med J; 2014 Jan; 61(1):B4778. PubMed ID: 24393595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. East-West gradient in the incidence of inflammatory bowel disease in Europe: the ECCO-EpiCom inception cohort.
    Burisch J; Pedersen N; Čuković-Čavka S; Brinar M; Kaimakliotis I; Duricova D; Shonová O; Vind I; Avnstrøm S; Thorsgaard N; Andersen V; Krabbe S; Dahlerup JF; Salupere R; Nielsen KR; Olsen J; Manninen P; Collin P; Tsianos EV; Katsanos KH; Ladefoged K; Lakatos L; Björnsson E; Ragnarsson G; Bailey Y; Odes S; Schwartz D; Martinato M; Lupinacci G; Milla M; De Padova A; D'Incà R; Beltrami M; Kupcinskas L; Kiudelis G; Turcan S; Tighineanu O; Mihu I; Magro F; Barros LF; Goldis A; Lazar D; Belousova E; Nikulina I; Hernandez V; Martinez-Ares D; Almer S; Zhulina Y; Halfvarson J; Arebi N; Sebastian S; Lakatos PL; Langholz E; Munkholm P;
    Gut; 2014 Apr; 63(4):588-97. PubMed ID: 23604131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A 20-Year Temporal Change Analysis in Incidence, Presenting Phenotype and Mortality, in the Dutch IBDSL Cohort-Can Diagnostic Factors Explain the Increase in IBD Incidence?
    van den Heuvel TRA; Jeuring SFG; Zeegers MP; van Dongen DHE; Wolters A; Masclee AAM; Hameeteman WH; Romberg-Camps MJL; Oostenbrug LE; Pierik MJ; Jonkers DM
    J Crohns Colitis; 2017 Oct; 11(10):1169-1179. PubMed ID: 28430884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A four-decade analysis of the incidence trends, sociodemographic and clinical characteristics of inflammatory bowel disease patients at single tertiary centre, Kuala Lumpur, Malaysia.
    Mokhtar NM; Nawawi KNM; Verasingam J; Zhiqin W; Sagap I; Azman ZAM; Mazlan L; Hamid HA; Yaacob NY; Rose IM; Den ELN; Wan MS; Raja Ali RA
    BMC Public Health; 2019 Jun; 19(Suppl 4):550. PubMed ID: 31196184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of inflammatory bowel disease and phenotype at diagnosis in 2011: results of the Epi-IBD 2011 study in the Vigo area.
    Hernández V; de Castro ML; Salinas-Rojo M; Fernández A; Martínez-Ares D; Sanromán L; Pineda JR; Carmona A; Salgado-Álvarez C; Martínez-Cadilla J; Pereira S; García-Burriel JI; González-Portela C; Vázquez S; Rodríguez-Prada JI;
    Rev Esp Enferm Dig; 2022 Feb; 114(2):103-106. PubMed ID: 34154368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. INCIDENCE OF INFLAMMATORY BOWEL DISEASE: A SINGLE CENTRE RETROSPECTIVE STUDY.
    Oli AK; Maidur RN; Hurkadli PS; Javalgi AP; Javaregowda PK; Goni M
    Arq Gastroenterol; 2022; 59(3):345-351. PubMed ID: 36102430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammatory bowel disease: re-evaluation of the diagnosis in a prospective population based study in south eastern Norway.
    Moum B; Ekbom A; Vatn MH; Aadland E; Sauar J; Lygren I; Schulz T; Stray N; Fausa O
    Gut; 1997 Mar; 40(3):328-32. PubMed ID: 9135520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High incidence of Crohn's disease in Canterbury, New Zealand: results of an epidemiologic study.
    Gearry RB; Richardson A; Frampton CM; Collett JA; Burt MJ; Chapman BA; Barclay ML
    Inflamm Bowel Dis; 2006 Oct; 12(10):936-43. PubMed ID: 17012964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging inflammatory bowel disease demographics, phenotype, and treatment in South Asia, South-East Asia, and Middle East: Preliminary findings from the Inflammatory Bowel Disease-Emerging Nations' Consortium.
    Banerjee R; Pal P; Hilmi I; Ghoshal UC; Desai DC; Rahman MM; Dutta U; Mohiuddin SA; Al Mohannadi M; Philip M; Ramesh GN; Niriella MA; De Silva AP; de Silva HJ; Pisespongsa P; Limsrivilai J; Aniwan S; Nawarathne M; Fernandopulle N; Aye TT; Ni N; Al Awadhi S; Joshi N; Ngoc PTV; Kieu TV; Nguyen AD; Abdullah M; Ali E; Zeid A; Sollano JD; Saberi B; Omar M; Mohsin MN; Aftab H; Wai TM; Shastri YM; Chaudhuri S; Ahmed F; Bhatia SJ; Travis SPL;
    J Gastroenterol Hepatol; 2022 Jun; 37(6):1004-1015. PubMed ID: 35178742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology of inflammatory bowel diseases in the state of Rio Grande do Sul, Brazil.
    Cassol OS; Zabot GP; Saad-Hossne R; Padoin A
    World J Gastroenterol; 2022 Aug; 28(30):4174-4181. PubMed ID: 36157112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of inflammatory bowel disease in the Australian general practice population: A cross-sectional study.
    Busingye D; Pollack A; Chidwick K
    PLoS One; 2021; 16(5):e0252458. PubMed ID: 34043730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of dementia in patients with inflammatory bowel disease: a Danish population-based study.
    Rønnow Sand J; Troelsen FS; Horváth-Puhó E; Henderson VW; Sørensen HT; Erichsen R
    Aliment Pharmacol Ther; 2022 Sep; 56(5):831-843. PubMed ID: 35781292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Point Prevalence of Pediatric Inflammatory Bowel Disease in New Zealand in 2015: Initial Results from the PINZ Study.
    Lopez RN; Evans HM; Appleton L; Bishop J; Chin S; Mouat S; Gearry RB; Day AS
    Inflamm Bowel Dis; 2017 Aug; 23(8):1418-1424. PubMed ID: 28570430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.